Related Experiment Video
Updated: Feb 26, 2026

Aip1p Dynamics Are Altered by the R256H Mutation in Actin
Published on: July 30, 2014
The cardiomyopathy-associated K15N mutation in tropomyosin alters actin filament pointed end dynamics
Mert Colpan1, Thu Ly2, Samantha Grover2
1Voiland School of Chemical Engineering & Bioengineering, Washington State University, Pullman, WA 99164-6515, United States; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ 85721, United States.
Abstract:
Correct assembly of thin filaments composed of actin and actin-binding proteins is of crucial importance for properly functioning muscle cells. Tropomyosin (Tpm) mediates the binding of tropomodulin (Tmod) and leiomodin (Lmod) at the slow-growing, or pointed, ends of the thin filaments. Together these proteins regulate thin filament lengths and actin dynamics in cardiac muscle. The K15N mutation in the TPM1 gene is associated with familial dilated cardiomyopathy (DCM) but the effect of this mutation on Tpm's function is unknown. In this study, we introduced the K15N mutation in striated muscle α-Tpm (Tpm1.1) and investigated its interaction with actin, Tmod and Lmod. The mutation caused a ∼3-fold decrease in the affinity of Tpm1.1 for actin. The binding of Lmod and Tmod to Tpm1.1-covered actin filaments also decreased in the presence of the K15N mutation. Furthermore, the K15N mutation in Tpm1.1 disrupted the inhibition of actin polymerization and affected the competition between Tmod1 and Lmod2 for binding at the pointed ends. Our data demonstrate that the K15N mutation alters pointed end dynamics by affecting molecular interactions between Tpm1.1, Lmod2 and Tmod1.
Related Concept Videos
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate....
The Sarcomere
Each...
Actin and Myosin in Muscle Contraction
The Role of Actin and Myosin in Non-muscle Cells
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

